Recombinant IgG (Immunoglobulin Gamma Heavy Chain) (B-Cell Marker) Antibody [rIGHG1/13035]

In Stock
Catalog Number Formulation Size Price
3500-MSM15-P0
Purified Ab with BSA and Azide at 200ug/ml
20ug
$259.00
3500-MSM15-P1
Purified Ab with BSA and Azide at 200ug/ml
100ug
$559.00
3500-MSM15-P1ABX
Purified Ab WITHOUT BSA or Azide at 1.0mg/ml
100ug
$559.00
Flat Rate Domestic: $95 | Orders outside the US - Contact Us for Order Information | Ships next business day

Summary

Recognizes a protein of 75kDa, identified as gamma heavy chain of human immunoglobulins. It does not cross-react with alpha (IgA), mu (IgM), epsilon (IgE), or delta (IgD), heavy chains, T-cells, monocytes, granulocytes, or erythrocytes. This MAb is useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin’s lymphomas. The most common feature of these malignancies is the restricted expression of a single heavy chain class. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is clonal and therefore malignant.

Product Properties & Targets

Host
Mouse
Applications
Species Reactivity
Isotype / Light Chain
IgG2b / Kappa
Gene Name
Positive Control
293T, Raji or hPBL cells. Human tonsil or spleen.
Immunogen
Human immunoglobulin heavy constant gamma 1 (G1m marker)
Alternate Names
immunoglobulin heavy constant gamma 1 (G1m marker)

Database Links

Entrez Gene ID
SwissProt

Additional Information

Clone
rIGHG1/13035
Expression System
CHO Cells
Purification
Protein A

Storage & Stability

Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

Limitations

This antibody is available for research use only and is not approved for use in diagnosis.

Supplied as

200ug/ml of Ab produced in a mammalian-based expression system. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.

Warranty

There are no warranties, expressed or implied, which extend beyond this description. Company is not liable for any personal injury or economic loss resulting from this product.
PARTNERSHIP OPPORTUNITIES

NeoBiotechnologies holds Exclusive rights to 10,000 recombinant and hybridoma antibody products, available for Licensing or Collaboration.

LETS TALK